Nifedipine and Erythromelalgia
Authors: JEFFREY R. FISHER
Journal: Annals of Internal Medicine (1983)

Letters and Corrections1 May 1983Nifedipine and ErythromelalgiaJEFFREY R. FISHER, M.D., MARVIN B. PADNICK, M.D., SIMON OLSTEIN, M.D.JEFFREY R. FISHER, M.D.Search for more papers by this author, MARVIN B. PADNICK, M.D.Search for more papers by this author, SIMON OLSTEIN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-98-5-671_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Erythromelalgia, a skin eruption with intense red discoloration, elevated skin temperature, and burning pain, usually involves the hands, feet, or lower legs. Most cases are idiopathic (1), but the condition also occurs in a familial form (2) and in association with myeloproliferative disorders, diabetes mellitus, venous insufficiency, hypertension, rheumatoid arthritis, and systemic lupus erythematosus (1-3). An erythromelalgia-like eruption has been reported in patients treated with bromocriptine (4). To our knowledge, this cutaneous reaction has not been seen with the use of other medications.A 44-year-old woman with Prinzmetal's angina had intermittent chest pain, unrelieved by oral nitrates...References1. JUERGENSSPITTELLFAIRBAIRN JJJ eds. Peripheral Vascular Diseases. 5th ed. Philadelphia: W.B. Saunders Co.; 1980: 601-5. Google Scholar2. BURBANKSPITTELLFAIRBAIRN MJJ Familial erythromelalgia: genetic and physiologic observations [Abstract]. J Lab Clin Med. 1966;68:861. Google Scholar3. JØRGENSENSØNDERGAARD HJ. Pathogenesis of erythromelalgia. Arch Dermatol. 1978;114:112-4. CrossrefMedlineGoogle Scholar4. EISLERHALLLALVARACALNE TRKD. Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine. Neurology (NY). 1981;31:1368-70. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Maryvale Samaritan Hopsital Phoenix, AZ 85031 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByDrug repurposing in Raynaud's phenomenon through adverse event signature matching in the World Health Organization pharmacovigilance databaseErythromelalgie: rote Haut und SchmerzThe spectrum of nephrocutaneous diseases and associationsErythromelalgiaDrug ReactionsErythromelalgiaAdverse Dermatologic Effects of Cardiovascular Drug Therapy: Part IIHigh-Dose Oral Magnesium Treatment of Chronic, Intractable ErythromelalgiaErythromelalgia: New theories and new therapiesThe spectrum of cutaneous reactions associated with diltiazem: Three cases and a review of the literaturePossible Erythromelalgia-Like Syndrome Associated with Nifedipine in a Patient with Raynaud's PhenomenonVerapamil-induced secondary erythermalgiaIn vitro phototoxicity of nifedipine: Sequential induction of toxic and non-toxic photoproducts with UVA radiationErythromelalgia: Review of clinical characteristics and pathophysiologyProbleme bei der Behandlung mit KalziumantagonistenErythromelalgia*Side Effects — Overdosage — Contraindications — Drug InteractionsExfoliative dermatitis due to nifedipineAngioedema from calcium channel blockersNebenwirkungen — Überdosierung (Vergiftung) — Kontraindikationen — ArzneimittelinteraktionenCalcium Channel blockers: Spectrum of Side Effects and Drug InteractionsUrticaria pigmentosa responsive to nifedipineNifedipine and ErythromelalgiaGEORGE J. BRODMERKEL JR., M.D. 1 May 1983Volume 98, Issue 5_Part_1Page: 671-672KeywordsAnginaDiabetes mellitusHypertensionIschemiaLupus erythematosusMyeloproliferative disordersNitratesPainRheumatoid arthritisTemperature Issue Published: 1 May 1983 PDF DownloadLoading ...